ポイントオブケア血糖検査の市場規模、シェア、成長分析、タイプ別、用途別、エンドユーザー別、地域別 - 産業予測、2025～2032年

ポイントオブケア血糖検査市場規模は2023年に34億4,000万米ドルと評価され、2024年の35億8,000万米ドルから2032年には49億8,000万米ドルに成長し、予測期間（2025-2032年）のCAGRは4.2%で成長する見通しです。

世界のポイントオブケア血糖検査市場は、糖尿病有病率の上昇と、便利で即時のグルコースモニタリングソリューションへの需要に後押しされて、大幅な成長を遂げています。ポータブル検査機器により、ヘルスケア専門家と患者は、ケアの時点で迅速に血糖値を評価することができ、より良い疾患管理と患者の転帰の改善を促進します。市場の拡大は、技術の進歩と日常的なグルコースモニタリングの重要性に対する意識の高まりによって支えられています。しかし、機器の価格や検査精度の確保といった課題には注意を払う必要があります。特に、新たなバイオセンサー技術やデジタルヘルスプラットフォームとの統合など、技術革新の機会は豊富にあり、糖尿病管理を強化し、世界中の患者に力を与えることで、最終的にはケアの合理化とヘルスケアコストの削減を目指す市場になります。

目次

イントロダクション

• 調査の目的
• 調査範囲
• 定義

調査手法

• 情報調達
• 二次データと一次データの方法
• 市場規模予測
• 市場の前提条件と制限

エグゼクティブサマリー

• 世界市場の見通し
• 供給と需要の動向分析
• セグメント別機会分析

市場力学と見通し

• 市場概要
• 市場規模
• 市場力学
  • 促進要因と機会
  • 抑制要因と課題
• ポーターの分析

主な市場の考察

• 重要成功要因
• 競合の程度
• 主な投資機会
• 市場エコシステム
• 市場の魅力指数（2024年）
• PESTEL分析
• マクロ経済指標
• バリューチェーン分析
• 価格分析

ポイントオブケア血糖検査市場規模：タイプ別

• 市場概要
• 穿刺器具とストリップ
• 血糖値測定器

ポイントオブケア血糖検査市場規模：用途別

• 市場概要
• 1型糖尿病
• 2型糖尿病

ポイントオブケア血糖検査市場規模：エンドユーザー別

• 市場概要
• 病院と診療所
• ホームケア設定
• その他

ポイントオブケア血糖検査市場規模

• 北米
  • 米国
  • カナダ
• 欧州
  • ドイツ
  • スペイン
  • フランス
  • 英国
  • イタリア
  • その他欧州地域
• アジア太平洋地域
  • 中国
  • インド
  • 日本
  • 韓国
  • その他アジア太平洋地域
• ラテンアメリカ
  • ブラジル
  • その他ラテンアメリカ地域
• 中東・アフリカ
  • GCC諸国
  • 南アフリカ
  • その他中東・アフリカ

競合情報

• 上位5社の比較
• 主要企業の市場ポジショニング（2024年）
• 主な市場企業が採用した戦略
• 市場の最近の動向
• 企業の市場シェア分析（2024年）
• 主要企業の企業プロファイル
  • 会社概要
  • 製品ポートフォリオ分析
  • セグメント別シェア分析
  • 収益の前年比比較（2022-2024）

主要企業プロファイル

• Abbott Laboratories（USA）
• Roche Holding AG（Switzerland）
• Ascensia Diabetes Care Holdings AG（Switzerland）
• Dexcom, Inc.（USA）
• Medtronic plc（Ireland）
• LifeScan, Inc.（USA）
• Becton, Dickinson and Company（BD）（USA）
• ACON Laboratories, Inc.（USA）
• Nova Biomedical Corporation（USA）
• ARKRAY, Inc.（Japan）
• Trividia Health, Inc.（USA）
• PTS Diagnostics（USA）
• Nipro Corporation（Japan）
• Ypsomed Holding AG（Switzerland）
• Sanofi S.A.（France）
• EKF Diagnostics Holdings plc（UK）
• Prodigy Diabetes Care, LLC（USA）
• Bayer AG（Germany）
• Danaher Corporation（USA）
• Platinum Equity Advisors, LLC（USA）

結論と推奨事項

Point-of-care Glucose Testing Market size was valued at USD 3.44 Billion in 2023 and is poised to grow from USD 3.58 Billion in 2024 to USD 4.98 Billion by 2032, growing at a CAGR of 4.2% during the forecast period (2025-2032).

The global point-of-care glucose testing market is experiencing substantial growth, fueled by the rising prevalence of diabetes and the demand for convenient, immediate glucose monitoring solutions. Portable testing devices enable healthcare professionals and patients to rapidly assess blood sugar levels at the point of care, promoting better disease management and improved patient outcomes. The market's expansion is supported by advancements in technology and heightened awareness of the importance of routine glucose monitoring. However, challenges like device affordability and ensuring test accuracy need attention. Opportunities for innovation abound, particularly with emerging biosensor technologies and integration with digital health platforms, positioning the market to enhance diabetes management and empower patients worldwide, ultimately aiming to streamline care and reduce healthcare costs.

Top-down and bottom-up approaches were used to estimate and validate the size of the Point-Of-Care Glucose Testing market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Point-Of-Care Glucose Testing Market Segmental Analysis

Global Point-Of-Care Glucose Testing Market is segmented by type, application, end user and region. Based on type, the market is segmented into lancing devices and strips and blood-glucose meter. Based on application, the market is segmented into type-1 diabetes and type-2 diabetes. Based on end user, the market is segmented into hospitals and clinics, home care settings and others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Point-Of-Care Glucose Testing Market

One of the primary catalysts for growth in the point-of-care glucose testing market is the rising prevalence of diabetes worldwide. As reported by the International Diabetes Federation, the number of adults diagnosed with diabetes is projected to soar to 700 million by 2045. This alarming increase highlights the critical need for consistent glucose monitoring to manage the condition effectively. Consequently, the growing population of diabetes patients significantly boosts the demand for point-of-care testing devices, which offer timely and convenient monitoring solutions. This trend underscores the vital role that these testing systems play in improving patient care and health outcomes in diabetes management.

Restraints in the Point-Of-Care Glucose Testing Market

One significant restraint on the Point-of-Care Glucose Testing market is the high cost associated with testing devices and related consumables. This financial barrier can impede market expansion, especially in developing areas where healthcare resources are scarce, and disposable incomes are lower. The elevated prices of these testing devices may deter extensive adoption, particularly within low-income populations and healthcare institutions operating under budget limitations. As a result, the affordability issue poses a challenge to the accessibility of point-of-care glucose testing, thereby affecting its utilization and potential growth in various regions where economic constraints exist.

Market Trends of the Point-Of-Care Glucose Testing Market

The Point-Of-Care Glucose Testing market is increasingly characterized by the integration of testing devices with digital health platforms and electronic health records. This trend, gaining momentum through 2022 and beyond, facilitates seamless data transfer and real-time monitoring of glucose levels, enhancing patient engagement in diabetes management. By empowering individuals with actionable insights and enabling healthcare professionals to access comprehensive patient data, this integration supports informed decision-making and personalized treatment plans. As technology continues to advance, the demand for interconnected health solutions is expected to grow, driving innovations in the Point-Of-Care Glucose Testing sector and improving patient outcomes.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis

Global Point-Of-Care Glucose Testing Market Size by Type & CAGR (2025-2032)

• Market Overview
• Lancing Devices and Strips
• Blood-Glucose Meter

Global Point-Of-Care Glucose Testing Market Size by Application & CAGR (2025-2032)

• Market Overview
• Type-1 Diabetes
• Type-2 Diabetes

Global Point-Of-Care Glucose Testing Market Size by End User & CAGR (2025-2032)

• Market Overview
• Hospitals and Clinics
• Home Care Settings
• Others

Global Point-Of-Care Glucose Testing Market Size & CAGR (2025-2032)

• North America (Type, Application, End User)
  • US
  • Canada
• Europe (Type, Application, End User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Type, Application, End User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Type, Application, End User)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Type, Application, End User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• Abbott Laboratories (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Roche Holding AG (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Ascensia Diabetes Care Holdings AG (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Dexcom, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Medtronic plc (Ireland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• LifeScan, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Becton, Dickinson and Company (BD) (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• ACON Laboratories, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Nova Biomedical Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• ARKRAY, Inc. (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Trividia Health, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• PTS Diagnostics (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Nipro Corporation (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Ypsomed Holding AG (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sanofi S.A. (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• EKF Diagnostics Holdings plc (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Prodigy Diabetes Care, LLC (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bayer AG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Danaher Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Platinum Equity Advisors, LLC (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations